image

In an attempt to revolutionize the field of personalized medicine, Scripps Health has partnered with the Gary and Mary West Foundation and Qualcomm to found the West Wireless Health Institute, a sister institute to the STSI.

The WWHI mission is to advance global health and well-being by identifying, validating, and accelerating the use of innovative and cost-effective personal remote-use wireless solutions for diagnostic and therapeutic purposes in critical and as-of-yet unmet medical and community needs.

The world-wide rate of chronic disease is increasing dramatically. In parallel, chronic diseases largely attributable to our lifestyle choices (e.g., diet, exercise, smoking, and substance abuse) are also on the rise. Aging of the global population is also making elderly care management a priority. As a result, the health care industry is facing an increased financial burden in dealing with increased hospitalization and treatment costs.
WWHI research will focus on:

  1. Preempting disease
  2. Disease management
  3. Aging in place
  4. Reaching medically underserved groups

As a founding partner of the WWHI, Scripps will head the development of wireless (i.e., wearable, implantable, ingestible) sensors for use in health and wellness management. STSI will draw on the expertise of the clinical staff at Scripps Health and its affiliates to work with biomedical engineers to develop and optimize these technologies for use in ambulatory and clinical settings. STSI will also oversee the validation of these devices through randomized clinical trials in multicenter networks.

Recent News

West Health Investment Fund created to lower health care costs

The co-founders of the West Wireless Health Institute announced this week a new $100 million investment fund, focusing on health care technologies, data analytics, technology-enabled services, cost transparency, and interoperability with the main goal of lowering health care costs. The fund will differ from traditional investment funds because it will not charge a management fee nor will there be carried interest, instead returns will be used to spur more medical research.